Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bulletin from the annual general meeting in Klaria Pharma Holding AB (publ)

Today, the annual general meeting of 2023 was held in Klaria Pharma Holding AB (publ). Below follows a summary of the resolutions passed at the annual general meeting (all in accordance with the proposals presented in the notice to attend the meeting kept available at the company’s website www.klaria.com). · It was resolved to adopt the profit and loss statement and the balance sheet and the group profit and loss statement and the group balance sheet for the financial year 2022. · It was resolved that the company’s available funds shall be carried forward in new account. · It was

OrganoWood AB has become certified as a climate-neutral company

OrganoWood AB continues to lead the way for sustainable development in the construction industry and is now certified as a climate-neutral company. - Ever since the start in 2010, we at OrganoWood have pursued the vision of a society free from biocides and heavy metals. Contributing to sustainable environments and a better world to live in is our driving force. Sustainability has been part of our corporate philosophy since the beginning. It is becoming increasingly important and today the environmental aspect should be decisive for consumers. We are therefore very proud that we

STOREBRAND ASA: Continuation of the Share Buyback Program

In a stock exchange announcement of 12 April 2023, Storebrand announced that there will be a temporary pause the share buyback program ("the Program") until a new authorisation had been adopted by the Annual General Meeting of Storebrand ASA, and the Financial Supervisory Authority had granted a renewed permission based on this authorisation. The Financial Supervisory Authority has now granted a renewed permission to continue the Program in accordance with the authorization adopted by the Annual General Meeting on 13 April 2023. The buyback program will therefore resume within the

Salmon Evolution ASA: New share capital registered - Private Placement Tranche 2

Reference is made to the stock exchange announcement on 19 April 2023 by Salmon Evolution ASA (“Salmon Evolution” or the “Company”) regarding the successfully placed private placement as described therein (the “Private Placement”) and the stock exchange announcement on 11 May 2023 by the Company regarding the resolution by the extraordinary general meeting to issue 16,318,598 new shares (the “New Shares”) in Tranche 2 of the Private Placement in the Company. The share capital increase pertaining to the issuance of the New Shares has today been registered with the Norwegian Register of

Positive results for Eli Lilly in Alzheimer’s

Last year, Biogen, Eisai and Swedish BioArctic scored big with a positive phase III readout in Alzheimer´s disease. Now, Eli Lilly follows with a second positive phase III readout with their Alzheimer´s candidate donanemab. While adding to the competition, Eli Lilly’s latest results also further validate the amyloid beta antibody approach.Read the full article at biostock.se : https://www.biostock.se/en/2023/05/positive-results-for-eli-lilly-in-alzheimers/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Return to ‘dark green’ status for Handelsbanken’s Paris-Aligned funds

The European Commission has recently presented a set of clarifications regarding sustainable investments, and has provided additional details on funds that track Paris-Aligned Benchmarks. In the wake of this news, Handelsbanken Fonder has made the decision to again report its Paris-Aligned Benchmark funds in accordance with Article 9.3, also called ‘dark green’. “This is an important step on the journey towards the goal of net zero emissions from our portfolios by 2040, and that assets are to be managed in accordance with the goals of the Paris Agreement”, says Emma Viotti, Head of

WindowMaster International A/S receives supplementary project order: Mary Elizabeth’s Hospital is now one of our largest projects ever

Investor News No. 003 - 2023 WindowMaster has received a supplementary order for the provision of controls of 436 solar shades in the iconic winter gardens at Mary Elizabeth’s Hospital – Rigshospitalet for Children, Teens and Expecting Families in Copenhagen. This supplementary order succeeds a contract from 2022. This includes intelligent control of the building's solar shading, comfort ventilation, and SHEV. Additionally, WindowMaster’s services cover the complete range of installation services related to these systems. These constitute project-, contract- and construction

BioStock: Annexin’s CMO on study results and participation in ARVO

Biotech company Annexin Pharmaceuticals earlier announced encouraging first results in one of two studies evaluating the candidate ANXV in retinal vein occlusion. In the imaging study SIGHT, data from the first patient show that the candidate binds to the desired area and target molecule. The results provide support for the continued development of ANXV as a treatment for the disease. CMO/CSO and Co-founder Anna Frostegård tells BioStock more about the results and the ARVO congress that the company recently participated in.Read the interview with Annexin Pharmaceuticals' CMO/CFO and Co-

RaySearch to present the latest advances in RayStation, RayCare and RayIntelligence at ESTRO 2023

RaySearch will be showcasing the latest software innovations at ESTRO in Vienna, May 12-15. Attendees will be able to book demonstrations of RayStation®* treatment planning system, RayCare®* oncology information system, and the cloud-based oncology analytics system RayIntelligence® during the congress. In addition to eight dedicated demo stations, RaySearch will also, togheter with industry partners Vision RT, Accuray, GE Healthcare, and Leo Cancer Care, present innovative joint solutions in cancer care.The latest version of RayStation includes among others new and updateted segmentation

Host Mobility Partners with Avassa to Bring Container Application Management to their Tailored Edge Hardware Solution

Stockholm, Sweden. Avassa, a provider of a container application management platform for the edge, is pleased to announce a partnership with Host Mobility, an expert manufacturer of custom edge hardware solutions. The collaboration will allow Host Mobility customers to securely and remotely install, run and lifecycle manage containerized applications on their hardware, which is typically installed in trucks, buses, or other distributed edge environments.Avassa's container application management platform offers robust orchestration, monitoring, and versioning capabilities, which will help

Flowscape's solution for office rightsizing wins business in Europe

An American Fortune 500 technology company chooses Flowscape's smart sensor solution to measure office utilization at one of their offices in Europe. The order value for the first year is Euro 37,500 (420,000 SEK) and thereafter Euro 30,900 (350,000 SEK) annually recurring revenue."We see that the hybrid way of working at offices is globally dominating. When employees work from home for two or more days per week, it has a major impact on occupancy levels at the offices. Our customers see a great need to measure and understand how their offices are used in more detail. Flowscape is a leader

DanCann Pharma A/S is strengthening its regulatory focus by appointing a life science lawyer to the board of directors

Copenhagen, Denmark, May 12, 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or "the Company"), a Danish company powered by cannabinoids, hereby announces the nomination of Louise Bertelsen Forman to join the board of directors at the upcoming annual general meeting on May 30, 2023.[Louise Bertelsen Forman] Louise Bertelsen Forman is an equity partner and attorney at the law firm Loeven, which specializes in the life science field. With over 10 years of experience in the industry, Louise is known for her "can-do attitude" and extensive industry knowledge, which

Zalaris signs master services agreement with global retailer for payroll services

Zalaris, a global provider of payroll and HR solutions, has signed a master services agreement for payroll services with a leading global retailer. Initially, the services will cover the customers 3,000+ employees in Denmark.Zalaris will deliver a PeopleHub based payroll solution  as Software-as-a-Service (SaaS) integrated to the customers global SuccessFactors based HR solution. The solution will be implemented over a period of 12 months.    “This is another example of the demand Zalaris is experiencing for our payroll

Change in YIT’s Investor Relations: Essi Nikitin appointed Vice President, Investor Relations of YIT

YIT Corporation Investor News 12 May 2023 at 10:00 a.m.Essi Nikitin (M.Sc. Econ) has been appointed Vice President, Investor Relations of YIT Corporation as of 4 August, 2023. Essi joins YIT from Musti Group, where she has worked as Head of Investor Relations and Communications. Before joining Musti Group, Essi has been working as a senior advisor of financial communications and investor relations at Miltton. In addition, Essi has worked in various investor relations positions at Sampo plc for over 10 years. Essi will report to CFO Tuomas Mäkipeska.  “I warmly welcome Essi to YIT. Her

UPM Biochemicals further expands distribution network for its new sustainable Renewable Functional Fillers (RFF)

Picture_UPM RFF Distribution Network_May 2023 [Participants at this year’s UPM RFF Distribution Summit in Leuna, Germany.] Participants at this year’s UPM RFF Distribution Summit in Leuna, Germany. (UPM, Helsinki, 12.05.2023 at 10:00 EEST) – UPM Biochemicals  announced today that it has further expanded its distribution network in Europe and Turkey for its UPM BioMotion™ Renewable Functional Fillers (RFF), an innovative new category of bio-based products. This strong distribution partner network expands the reach of RFF into new markets and will

BioStock: Status update from CombiGene's CEO

With the first quarter of the year concluded, CombiGene's CEO Jan Nilsson visited BioStock's studio for a status update on the gene therapy company's project. Nilsson not only talks about the pain project COZY and the epilepsy candidate CG01, but also about the company's financial status.Watch the interview with Jan Nilsson at biostock.se: https://www.biostock.se/en/2023/05/status-update-from-combigenes-ceo/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

The last day of trading with the warrants of series TO6 in Svenska Aerogel Holding AB is today, May 12, 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Today, May 12, 2023, is the last day of trading with the warrants of series TO6 in Svenska Aerogel Holding AB (“Svenska Aerogel” or “the Company”). The subscription period for

NOTICE OF ANNUAL GENERAL MEETING 2023 IN DANCANN PHARMA A/S

NOTICE OF ANNUAL GENERAL MEETING 2023 IN DANCANN PHARMA A/S The Board of Directors hereby convenes the annual general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”), to be held on Tuesday, 30 May 2023 at 09:00 am (CET) at DanCann Pharma A/S’ address, Rugvænget 5, 6823 Ansager, Denmark The agenda for the annual general meeting is as follows: 6. `. 1. 1. 1. 1. 1. The chairman’s report on the activities of the Company in the past financial year 2. Adoption of the annual report for 2022

Interim report Q3, 2023

Company Announcement no. 25-23Copenhagen, May 12, 2023 This announcement is a summary and should be read in conjunction with Shape Robotics’ interim report for Q1 2023, published on May 12, 2023. The interim report will be available on the company’s website . Financial highlights Q1, 2023 (Jan-Mar) · The Company has realized a revenue of MDKK 18.9 (Q1 2022 MDKK 7.1), corresponding to a revenue growth of 166% · Contribution Margin amounts to MDKK 6.0 (Q1 2022 MDKK 2.6) · Contribution Margin in % YTD amounts to 31% (Q1 37%) ·

DanCann Pharma A/S publishes Annual Report 2022

COPENHAGEN, Denmark, 12 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that The Board of Directors and the Chief Executive Officer of DanCann Pharma publishes the annual report of the year 2022. The annual report is available in this press release and on the website of DanCann Pharma.For more information, visit: https://www.dancann.com/investor-relations. About DanCann Pharma A/S DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) was founded in 2018 and is a Danish biopharmaceutical

NYAB Plc's business review 1 January - 31 March 2023: Accelerating balanced growth

NYAB PlcCOMPANY ANNOUNCEMENT12 May 2023 at 09:45NYAB Plc’s business review 1 January – 31 March 2023: Accelerating balanced growth · Revenue was EUR 39.2 (11.6) million, an increase of 34 percent from pro forma revenue of EUR 29.3 million for the comparison period. · EBITA was EUR -1.2 (-1.3) million, an improvement of 55 percent from pro forma EBITA of EUR -2.2 million for the comparison period. · Order backlog at the end of March was EUR 235.0 (156.3) million, an increase of 50 percent from March 2022. · After the review period, settlement agreement with the City of

ADDvise extends the agreement with Laborie at a value of SEK 48 million

ADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The agreement is giving Laborie the right to sell Sonesta Medical’s urology- and gynecology patient positioning equipment and video fluoroscopy tables worldwide, with an exclusive right to distribute in USA and some European countries. Laborie commits to a minimum volume of SEK 48 million. The term of the agreement is two years. The total value of the orders during the term of the agreement is at least SEK 48 million. Laborie is a leading global developer, manufacturer and

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

Company Announcement No. 55 -2023 OrderYOYO A/SManagers’ transactions   Copenhagen, May 12, 2023   OrderYOYO A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 (the market abuse regulation) of the below transactions related to shares in OrderYOYO A/S made by TJOYY22 ApS, closely associated to CEO Jesper Johansen, who has acquired 1,865 shares in OrderYOYO A/S at an average price of DKK 5 per share.  1. Details of the person discharging managerial responsibilities/person closely associateda) Name

There are no items matching the current filter
There are no more items matching the current filter
Back to top